CDER Emerging Drug Safety Technology Program (EDSTP)

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta charset="utf-8" /> <script async src="https://www.googletagmanager.com/gtag/js?id=G-273DTKB5QW"></script> <meta name="description" content="The EDSTP is specifically focused on the use of artificial intelligence and other emerging technologies in pharmacovigilance and is part of the Center for Drug Evaluation and Research. Learn more." /> <meta name="dcterms.title" content="CDER Emerging Drug Safety Technology Program (EDSTP)" /> <meta name="dcterms.creator" content="Center for Drug Evaluation and Research" /> <meta name="dcterms.description" content="The EDSTP is specifically focused on the use of artificial intelligence and other emerging technologies in pharmacovigilance and is part of the Center for Drug Evaluation and Research. Learn more." /> <meta name="dcterms.publisher" content="FDA" /> <meta name="dcterms.source" content="FDA" /> <meta property="og:site_name" content="U.S. Food and Drug Administration" /> <meta property="og:type" content="Article" /> <meta property="og:url" content="https://www.fda.gov/drugs/science-and-research-drugs/cder-emerging-drug-safety-technology-program-edstp" /> <meta property="og:title" content="CDER Emerging Drug Safety Technology Program (EDSTP)" /> <meta property="og:description" content="CDER Emerging Drug Safety Technology Program (EDSTP)" /> <meta property="og:updated_time" content="Mon, 06/10/2024 - 00:00" /> <meta property="article:published_time" content="Thu, 10/31/2024 - 14:30" /> <meta property="article:modified_time" content="Mon, 06/10/2024 - 00:00" /> <meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="@US_FDA" /> <meta property="twitter:description" content="CDER Emerging Drug Safety Technology Program (EDSTP)" /> <meta name="twitter:title" content="CDER Emerging Drug Safety Technology Program (EDSTP)" /> <meta name="twitter:creator" content="@US_FDA" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <script type="application/ld+json">{ "@context": "https://schema.org", "@graph": [ { "@type": "Article", "headline": "CDER Emerging Drug Safety Technology Program (EDSTP)", "name": "CDER Emerging Drug Safety Technology Program (EDSTP)", "description": "The EDSTP is specifically focused on the use of artificial intelligence and other emerging technologies in pharmacovigilance and is part of the Center for Drug Evaluation and Research. Learn more.", "datePublished": "Thu, 10/31/2024 - 14:30", "dateModified": "Mon, 06/10/2024 - 00:00", "author": { "@type": "Organization", "name": "Center for Drug Evaluation and Research" }, "publisher": { "@type": "Organization", "name": "FDA" } } ] }</script> <meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <link rel="icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" /> <link rel="alternate" hreflang="en" href="https://www.fda.gov/drugs/science-and-research-drugs/cder-emerging-drug-safety-technology-program-edstp" /> <link rel="canonical" href="https://www.fda.gov/drugs/science-and-research-drugs/cder-emerging-drug-safety-technology-program-edstp" /> <link rel="shortlink" href="https://www.fda.gov/node/422037" /> <script src="/files/google_tag/production/google_tag.script.js?spd7fh" defer></script> <title>CDER Emerging Drug Safety Technology Program (EDSTP) | FDA</title> <link rel="stylesheet" media="all" href="/files/css/css_Q5MKErtMfgovWieJAvszblpLfhOcAt5cieNb9a94aTU.css?delta=0&language=en&theme=preview&include=eJxlkFGOwyAMRC9EQ38q7W2QY1yCCjbCTqvs6Zu0ahrt_qBhLI3fGG8Us0kPmSOxjUXw5g_aXYUNHqRSyR_04JJIKhSAoSyWUf1fw-miRtWPoORap3umh09FRigntaVkTv9s7LmZulHE1Do036TJnbq7Rgj4YSWegJHqCqkeEKXHLBxM0gagk3RDieS2aPWvd6gS50LvHKmt5C3hPQuX88_BdA06pHX5pD72uUEZvs4wc5vHknWiuN5GjMVI_a72Rtjhd6H0rRihvaA-_x3ztDd4AlQhnP0" /> <link rel="stylesheet" media="all" href="/files/css/css_xLeUZALg1CD0YmiSIzZnqkwKfNF_g3TkAjkxBt_uccA.css?delta=1&language=en&theme=preview&include=eJxlkFGOwyAMRC9EQ38q7W2QY1yCCjbCTqvs6Zu0ahrt_qBhLI3fGG8Us0kPmSOxjUXw5g_aXYUNHqRSyR_04JJIKhSAoSyWUf1fw-miRtWPoORap3umh09FRigntaVkTv9s7LmZulHE1Do036TJnbq7Rgj4YSWegJHqCqkeEKXHLBxM0gagk3RDieS2aPWvd6gS50LvHKmt5C3hPQuX88_BdA06pHX5pD72uUEZvs4wc5vHknWiuN5GjMVI_a72Rtjhd6H0rRihvaA-_x3ztDd4AlQhnP0" /> <script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script> <script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&subagency=FDA&sdor=fda.gov&dclink=true" language="javascript" id="_fed_an_ua_tag"></script> <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("set", "developer_id.dMDhkMT", true);gtag("config", "G-273DTKB5QW", {"groups":"default","page_placeholder":"PLACEHOLDER_page_location","allow_ad_personalization_signals":false});</script> </head> <body class="role-anonymous path-node page-node-type-sub-section has-glyphicons"> <div id="quicklinks" class="sr-only"> <ul> <li><a href="#main-content" class="sr-only sr-only-focusable" tabindex="1">Skip to main content</a></li> <li><a href="#search-form" class="sr-only sr-only-focusable" tabindex="1">Skip to FDA Search</a></li> <li><a href="#section-nav" class="sr-only sr-only-focusable" tabindex="1">Skip to in this section menu</a></li> <li><a href="#footer-heading" class="sr-only sr-only-focusable" tabindex="1">Skip to footer links</a></li> </ul> </div> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M95XGZW" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="main-container container-fluid"> <div class="row"> <header class="lcds-header container-fluid" role="heading" aria-level="1"> <div class="row us-masthead"> <div class="usa-banner col-xs-12"> <img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" /> <span>An official website of the United States government</span> <a id="USMenuButton" class="collapsed" data-toggle="collapse" data-target="#USABannerMenu" aria-controls="USABannerMenu">Here’s how you know <span class="toggle-indicator"> </span></a> <div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton"> <div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true"> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The .gov means it’s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p> </div> </div> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p> </div> </div> </div> </div> </div> </div> <div class="alert alert-warning margin-left-neg-2 margin-right-neg-2 margin-top-3 margin-bottom-1"> <p>On Oct. 1, 2024, the FDA began implementing a <a href="/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and" title="FDA Modernization Efforts for Establishing a Unified Human Foods Program, New Model for Field Operations and More">reorganization</a> impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.</p> </div> <div class="row fda-masthead"> <div class="col-xs-4 col-md-8"> <a href="/" title="FDA Homepage"> <h1 class="fda-masthead__fda-logo">U.S. Food and Drug Administration</h1> </a> </div> <div class="col-xs-8 col-md-4"> <ul class='fda-masthead__item-list'> <li><a title="" id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search"> <span class="fa fa-search" aria-hidden="true"> </span> <span class="fda-masthead__btn-label">Search</span> </a></li> <li><a id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true"> <span class="fa fa-bars" aria-hidden="true"> </span> <span class='fda-masthead__btn-label'>Menu</span> </a></li> </ul> </div> <form class="fda-masthead__search sr-only" role="search" action="/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8" > <div class="search-popover" id="search-popover"> <div class="input-group pull-right" id="search-group"> <label class="sr-only" for="search-query">Search FDA</label> <input class="form-control search-input" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text" /> <span class="input-group-btn" id="input-group-btn"> <button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button> </span> </div> </div> </form> </div> <nav id="primary-nav" class="lcds-primary-nav row collapse"> <div class="col-md-5 col-lg-4"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Featured</h2> <ul class="lcds-primary-nav__list lcds-primary-nav__list--featured"> <li class="lcds-primary-nav__list-item"><a href="https://www.safetyreporting.hhs.gov/smarthub#/" title="Report a Problem with an FDA Regulated Product">Report a Product Problem</a></li> <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li> <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li> <li class="lcds-primary-nav__list-item"><a href="/fda-en-espanol">En Espa&#241ol</a></li> </ul> </section> </div> <div class="col-md-7 col-lg-8"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Products</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li> <li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li> <li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li> <li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li> <li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li> <li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li> <li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Topics</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li> <li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li> <li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li> <li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li> <li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Information For</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li> <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li> <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li> <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li> <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li> </ul> </section> </div> </nav> </header> <div class="col-xs-12"> <div data-drupal-messages-fallback class="hidden"></div> </div> <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav">In this section<span class="visible-sm-inline-block">: Science and Research | Drugs </span> </a> <nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse"> <ul class="lcds-section-nav__list"> <li> <a href="/drugs/science-and-research-drugs/cder-emerging-drug-safety-technology-program-edstp" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link">CDER Emerging Drug Safety Technology Program (EDSTP)</a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-5ffd6564ab5372e6c61bd69c0d1ae90764e1dfc63e537ffaf0fde931afd4d95a"> <div> <ul class="lcds-section-nav__section-link__active lcds-section-nav__list"> <li><a href="/drugs/cder-emerging-drug-safety-technology-program-edstp/emerging-drug-safety-technology-meeting-edstm-program" class="lcds-section-nav__link">Emerging Drug Safety Technology Meeting (EDSTM) Program</a></li> </ul> </div> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-a4ada160c69f76fef2de963e590234c762eed0d20de3976635ae0f898e4d5795"> </div> </div> </li> </ul> </nav> </section> <section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <ol class="lcds-breadcrumb visible-md visible-lg"> <li > <a href="/">Home</a> </li> <li > <a href="/drugs">Drugs</a> </li> <li > <a href="/drugs/science-and-research-drugs">Science and Research | Drugs</a> </li> <li > <a class="current-link">CDER Emerging Drug Safety Technology Program (EDSTP)</a> </li> </ol> <ol class="lcds-breadcrumb visible-sm visible-xs"> <li> <a href="/drugs/science-and-research-drugs" title="Science and Research | Drugs"> Science and Research | Drugs </a> </li> </ol> </section> <main> <article id="main-content" class="article main-content container-fluid" role="article"> <header class="row content-header" role="heading" aria-level="1"> <section id="block-entityviewcontent-14" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="col-sm-12 col-md-8 col-md-offset-2"> <h1 class="content-title text-center">CDER Emerging Drug Safety Technology Program (EDSTP)</h1> <div class="lcds-toolbar lcds-toolbar--social"> <ul class="lcds-share lcds-share--default"> <li class="lcds-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https://www.fda.gov%2Fdrugs%2Fscience-and-research-drugs%2Fcder-emerging-drug-safety-technology-program-edstp" class="lcds-share__btn lcds-share--default__btn-facebook js-share" id="fb-share" target="_blank"><span class="fa icon-facebook" aria-hidden="true"></span>Share</a> </li> <li class="lcds-share__item"> <a href="https://x.com/intent/tweet/?text=CDER%20Emerging%20Drug%20Safety%20Technology%20Program%20%28EDSTP%29&url=https://www.fda.gov%2Fdrugs%2Fscience-and-research-drugs%2Fcder-emerging-drug-safety-technology-program-edstp" target="_blank" class="lcds-share__btn lcds-share--default__btn-x-twitter js-share" id="twitter-share"> <svg class="icon-svg-inline" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> Post </a> </li> <li class="lcds-share__item hidden-xs"> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https://www.fda.gov%2Fdrugs%2Fscience-and-research-drugs%2Fcder-emerging-drug-safety-technology-program-edstp&title=CDER%20Emerging%20Drug%20Safety%20Technology%20Program%20%28EDSTP%29&source=FDA" class="lcds-share__btn lcds-share--default__btn-linkedin js-share" id="linkedin-share" target="_blank"><span class="fa icon-linkedin" aria-hidden="true"></span>Linkedin</a> </li> <li class="lcds-share__item"> <a href="mailto:?subject=CDER%20Emerging%20Drug%20Safety%20Technology%20Program%20%28EDSTP%29&body=https://www.fda.gov%2Fdrugs%2Fscience-and-research-drugs%2Fcder-emerging-drug-safety-technology-program-edstp" class="lcds-share__btn lcds-share--default__btn-mail"><span class="fa icon-envelope" aria-hidden="true"></span>Email</a> </li> <li class=" lcds-share__item hidden-xs"> <a href="javascript:window.print();" title="Print this page" class="lcds-share__btn lcds-share--default__btn-print"><span class="fa icon-print" aria-hidden="true"></span>Print</a> </li> </ul> <div class="form-group"> </div> </div> </div> </section> </header> <div class="col-md-8 col-md-push-2" role="main"> <h2>Introducing the Emerging Drug Safety Technology Program (EDSTP)</h2> <div alt="Abstract network and data background." data-embed-button="media_browser" data-entity-embed-display="media_image" data-entity-embed-display-settings="Array" data-entity-type="media" data-entity-uuid="74ca1805-f2a6-4e8e-866a-79492e68e8ee" data-langcode="en" title="Data Network Background" class="align-right embedded-entity"> <img loading="lazy" src="/files/Data%20Network%20Background.jpeg" alt="Abstract network and data background." title="Data Network Background" class="img-responsive"> </div> <p>The EDSTP is specifically focused on the use of artificial intelligence (AI) and other emerging technologies in pharmacovigilance (PV) and is part of the Center for Drug Evaluation and Research’s (CDER) multifaceted approach to enhance mutual learning of where and how specific innovations, such as AI, can best be used across the drug product lifecycle.  </p> <h2>Emerging Technology's Potential in PV and Safety Surveillance</h2> <p>FDA has a longstanding commitment to ensure medicines marketed in the United States are safe through continued surveillance and research following approval. In the postmarket setting, regulated industry (per 21 CFR 314.80, 314.98, and 600.80) is obligated to review all adverse drug experience information received or otherwise obtained and submit reports to FDA. Both industry and regulatory authorities face challenges with timely and efficient collection, processing, and evaluation of single and aggregate patient safety data compounded by ever-increasing case volumes. Advances in emerging technology have the potential to address some of these challenges by creating more efficiencies within a PV system. For example, early adopters of AI are leveraging these emerging technologies to automate fundamental tasks (e.g., adverse event intake, data entry, and processing) with the intention to drive down associated administrative burden and costs. These technologies can also make safety surveillance more efficient and effective by capturing, aggregating, and analyzing larger and more diverse data sets. </p> <h2>Goals of the EDSTP</h2> <p>CDER recognizes industry’s interest in dialogue around AI capabilities that advance PV. Industry may have concerns that using such technologies could create uncertainties regarding satisfying regulatory obligations for PV. This is especially true while CDER familiarizes itself with new technologies (e.g., assessing their performance characteristics and efforts to validate and verify models) to determine how they may be evaluated within our regulatory framework. </p> <p>In this context, CDER established the EDSTP with three goals: </p> <ul> <li>Serve as the central point of contact for discussion between industry and CDER on the use of AI and other emerging technologies in PV </li> <li>Enable knowledge management and knowledge transfer within FDA specific to the context of AI or other emerging technologies used in PV</li> <li>Understand the context of use of AI and other emerging technologies in PV to inform potential regulatory and policy approaches within PV</li> </ul> <p>To help further these goals, CDER created the <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="3612f8c7-d3db-4eea-a5ef-a10d844e4863" href="/drugs/cder-emerging-drug-safety-technology-program-edstp/emerging-drug-safety-technology-meeting-edstm-program" title="Emerging Drug Safety Technology Meeting (EDSTM) Program">Emerging Drug Safety Technology Meeting (EDSTM) program</a>, which will be administered by the EDSTP. FDA expects that increased communication with the broader pharmaceutical industry during EDSTMs will accelerate FDA’s understanding of how AI enabled tools and other emerging technologies are being used for PV, their performance characteristics, their associated risks and benefits, efforts to validate and verify relevant models, and barriers to implementation. </p> <h2>Questions and Answers</h2> <p></p><div class=" panel-group" id="accordion_674489" role="tablist" aria-multiselectable="true"> <p><a id="purpose" name="purpose"></a></p> <p> </p><div title="What is the purpose of the Emerging Drug Safety Technology Meeting (EDSTM)?" open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_67b6349ba3b90"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#67b6349ba3b90" aria-controls="67b6349ba3b90">What is the purpose of the Emerging Drug Safety Technology Meeting (EDSTM)?</a> </h2> </div> <div id="67b6349ba3b90" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_67b6349ba3b90"> <div class="panel-body"> <p>The EDSTM is a means by which eligible participants (see <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="3612f8c7-d3db-4eea-a5ef-a10d844e4863" href="/drugs/cder-emerging-drug-safety-technology-program-edstp/emerging-drug-safety-technology-meeting-edstm-program#eligibility" title="Emerging Drug Safety Technology Meeting (EDSTM) Program">Eligibility Criteria</a>) can meet with CDER to share information about their use of AI and other emerging technologies and its potential application in PV. The goal of the meeting is to facilitate mutual learning and discussion on the opportunities and challenges with using such technologies in PV. Those selected for a meeting will meet with CDER to discuss their research, development, and/or use of AI and other emerging technologies in PV.</p> <p> </p></div> </div> </div> <p><a id="reps" name="reps"></a></p> <p> </p><div title="Which FDA representatives will be involved in the EDSTMs?" open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_67b6349ba44d3"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#67b6349ba44d3" aria-controls="67b6349ba44d3">Which FDA representatives will be involved in the EDSTMs?</a> </h2> </div> <div id="67b6349ba44d3" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_67b6349ba44d3"> <div class="panel-body"> <p>EDSTMs will be attended by members of CDER’s Emerging Drug Safety Technology Program, which includes representatives from CDER staff with experience in emerging drug safety technologies, pharmacovigilance activities, policy, and relevant inspection programs (e.g., Postmarketing Adverse Drug Experience (PADE) Compliance Program). The relevant interdisciplinary experts attending an EDSTM will depend on the nature of the topic proposed by the meeting requester. Additional experts from other centers or offices may participate as resources and time permit.</p> <p> </p></div> </div> </div> <p><a id="topics" name="topics"></a></p> <p> </p><div title="What topics are of interest to CDER for EDSTMs?" open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_67b6349ba4574"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#67b6349ba4574" aria-controls="67b6349ba4574">What topics are of interest to CDER for EDSTMs?</a> </h2> </div> <div id="67b6349ba4574" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_67b6349ba4574"> <div class="panel-body"> <p>CDER is interested in a deeper understanding of AI and other emerging technologies that industry is exploring or has applied to PV activities. CDER is also interested in additional safety-related use cases involving emerging technology in PV, including but not limited to, signal detection and evaluation. The FDA <a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="41d01699-4bac-489b-9a82-c7df698d63c3" href="/about-fda/page-not-found">AI/ML for Drug Development Discussion Paper</a> references common uses of AI in PV, particularly for postmarket safety surveillance such as for the processing, evaluation, and submission of individual case safety reports (ICSRs) (see pages 8 – 9).</p> <p>When exploring use cases of AI and other emerging technologies in PV with industry in EDSTMs, CDER is also interested in understanding how industry establishes the credibility and trustworthiness of AI models, including the following areas of consideration:</p> <ul> <li>Human-led governance, accountability, transparency, and explainability</li> <li>Data quality, reliability, representativeness, and bias mitigation</li> <li>Model development, performance, monitoring, and validation.</li> </ul> <p>These areas of consideration are noted in the <a data-entity-substitution="media_download" data-entity-type="media" data-entity-uuid="41d01699-4bac-489b-9a82-c7df698d63c3" href="/about-fda/page-not-found">AI/ML for Drug Development Discussion Paper</a> (see pages 17 – 23).</p> <p> </p></div> </div> </div> <p><a id="when" name="when"></a></p> <p> </p><div title="When is CDER accepting requests for EDSTMs? When are the submission deadlines?" open="no" class=" panel panel-default fda-accordion-panel"> <div class="panel-heading" role="tab" id="heading_67b6349ba461f"> <h2 class="panel-title"> <a role="button" class="collapsed" data-toggle="collapse" data-parent href="#67b6349ba461f" aria-controls="67b6349ba461f">When is CDER accepting requests for EDSTMs? When are the submission deadlines?</a> </h2> </div> <div id="67b6349ba461f" class="panel-collapse collapse collapsed" role="tabpanel" aria-labelledby="heading_67b6349ba461f"> <div class="panel-body"> <p>CDER is now accepting requests for EDSTMs. Refer to the <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="3612f8c7-d3db-4eea-a5ef-a10d844e4863" href="/drugs/cder-emerging-drug-safety-technology-program-edstp/emerging-drug-safety-technology-meeting-edstm-program#timeline" title="Emerging Drug Safety Technology Meeting (EDSTM) Program">Submission Timeline and Process</a> for quarterly submission deadlines. Requests will be reviewed on a quarterly basis for a total of up to nine participants in a 12-month period for the initial phase of the EDSTM.</p> <p> </p></div> </div> </div> <p></p></div> <h2><a id="contact" name="contact"></a>Contact Us</h2> <p>For more information regarding CDER’s Emerging Drug Safety Technology Program (EDSTP), email <a href="mailto:AIMLforDrugDevelopment@fda.hhs.gov?subject=EDSTP">AIMLforDrugDevelopment@fda.hhs.gov</a> and include the subject line “EDSTP – General Inquiry”</p> <br> <div class="field field--name-field-sub-topic-paragraphs field--type-entity-reference-revisions field--label-above"> <div class="field--label">Sub-Topic Paragraphs</div> <div class="field--items"> <div class="field--item"> <section class="lcds-card-deck--promoted lcds-card-deck bg-lightest-gray"> <header class="lcds-card-deck__header"> <h2 class="lcds-card-deck__heading" >In this Section</h2> </header> <div class="lcds-card-deck__body"> <a href="/drugs/cder-emerging-drug-safety-technology-program-edstp/emerging-drug-safety-technology-meeting-edstm-program" title="Emerging Drug Safety Technology Meeting (EDSTM) Program"> <article class="lcds-card lcds-card--promoted lcds-card--promoted-subtopic bg-white"> <div> <div class="field field--name-image field--type-image field--label-hidden field--item"> <picture> <source srcset="/files/styles/thunbnail_3/public/ai_image_final_1600x900-01.png?itok=UERIZuoB 380w" media="all and (max-width: 320px)" type="image/png" sizes="100vw" width="380" height="200"/> <source srcset="/files/styles/thunbnail_3/public/ai_image_final_1600x900-01.png?itok=UERIZuoB 380w" media="all and (min-width: 321px) and (max-width: 480px)" type="image/png" sizes="100vw" width="380" height="200"/> <source srcset="/files/styles/medium_3/public/ai_image_final_1600x900-01.png?itok=gpy8DYLH 420w" media="all and (min-width: 481px) and (max-width: 767px)" type="image/png" sizes="100vw" width="420" height="220"/> <source srcset="/files/styles/medium_3/public/ai_image_final_1600x900-01.png?itok=gpy8DYLH 420w" media="all and (min-width: 768px) and (max-width: 992px)" type="image/png" sizes="100vw" width="420" height="220"/> <source srcset="/files/styles/medium_3/public/ai_image_final_1600x900-01.png?itok=gpy8DYLH 420w" media="all and (min-width: 993px) and (max-width: 1200px)" type="image/png" sizes="100vw" width="420" height="220"/> <source srcset="/files/styles/medium_3/public/ai_image_final_1600x900-01.png?itok=gpy8DYLH 420w" media="all and (min-width: 1201px)" type="image/png" sizes="100vw" width="420" height="220"/> <img loading="eager" src="/files/styles/medium_3/public/ai_image_final_1600x900-01.png?itok=gpy8DYLH" width="420" height="220" alt="Artificial intelligence thinking" class="img-responsive" /> </picture> </div> </div> <div class="lcds-card__body"> <h3 class="lcds-card__title">Emerging Drug Safety Technology Meeting (EDSTM) Program</h3> <p class="lcds-card__text"></p> </div> </article> </a> </div> </section></div> <div class="field--item"> <section class="lcds-card-deck--teaser lcds-card-deck txt-dark"> <header class="lcds-card-deck__header"> <h2 class="lcds-card-deck__heading" >Related Information</h2> </header> <div class="lcds-card-deck__body"> <article class="lcds-card lcds-card--border-top lcds-card--teaser lcds-card--teaser-subtopic"> <h3 class="lcds-card__title"><a href="/drugs/cder-conversations/cders-emerging-drug-safety-technology-meeting-program">CDER Conversation: CDER’s Emerging Drug Safety Technology Meeting Program</a></h3> <p class="lcds-card__text">Robert Ball, M.D., M.P.H., ScM, Deputy Director of CDER’s Office of Surveillance and Epidemiology, explains the EDSTM program and the application of AI in PV.</p> </article> <article class="lcds-card lcds-card--border-top lcds-card--teaser lcds-card--teaser-subtopic"> <h3 class="lcds-card__title"><a href="/science-research/focus-areas-regulatory-science-report/focus-area-artificial-intelligence">Focus Area: Artificial Intelligence</a></h3> <p class="lcds-card__text">FDA aims to improve its understanding of AI’s potential and limitations. Learn more.</p> </article> <article class="lcds-card lcds-card--border-top lcds-card--teaser lcds-card--teaser-subtopic"> <h3 class="lcds-card__title"><a href="/about-fda/center-drug-evaluation-and-research-cder/artificial-intelligence-drug-development">Artificial Intelligence and Machine Learning (AI/ML) for Drug Development</a></h3> <p class="lcds-card__text">FDA recognizes the increased use of AI/ML throughout the drug development life cycle. Learn more.</p> </article> <article class="lcds-card lcds-card--border-top lcds-card--teaser lcds-card--teaser-subtopic"> <h3 class="lcds-card__title"><a href="/science-research/science-and-research-special-topics/artificial-intelligence-and-medical-products">Artificial Intelligence and Medical Products</a></h3> <p class="lcds-card__text">Learn more about how the FDA is shaping the future of health care through the responsible and innovative integration of AI.</p> </article> <article class="lcds-card lcds-card--border-top lcds-card--teaser lcds-card--teaser-subtopic"> <h3 class="lcds-card__title"><a href="/news-events/fda-voices/fda-releases-two-discussion-papers-spur-conversation-about-artificial-intelligence-and-machine">FDA Discussion Papers on AI/ML in Drug Development and Manufacturing</a></h3> <p class="lcds-card__text">FDA recognizes the potential for AI/ML to enhance drug development in many ways. Learn more.</p> </article> </div> </section> </div> </div> </div> <br> </div> <aside class="col-md-2 col-md-push-2" role="complementary"> <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <aside class="lcds-card lcds-card--border-top" > <ul role="menu" class="lcds-description-list"> <li role="menuitem" class="node-current-date lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Content current as of:</h2> <p class="lcds-description-list__item-text"><time datetime="2024-06-10T00:00:00Z">06/10/2024</time> </p> </div> </li> <li role="menuitem" class="lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Regulated Product(s)</h2> <ul role="menu" class="lcds-metadata-list"> <li role="menuitem">Drugs</li> </ul> </div> </li> </ul> </aside> </div> </section> </aside> <aside class="col-md-2 col-md-pull-10" role="complementary"> <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm"> <ul class="lcds-section-nav__list lcds-section-nav--side__list"> <li> <a href="/drugs/science-and-research-drugs/cder-emerging-drug-safety-technology-program-edstp" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link">CDER Emerging Drug Safety Technology Program (EDSTP)</a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-cb70a57a6dd244e8a63a17b6fc7e68ee72c0759d7f4cc8f93b0d92ce0562a289"> <div class="item-list"> <ul class="lcds-section-nav__active lcds-section-nav__list lcds-section-nav--side__list"> <li><a href="/drugs/cder-emerging-drug-safety-technology-program-edstp/emerging-drug-safety-technology-meeting-edstm-program" class="lcds-section-nav__link lcds-section-nav--side__link">Emerging Drug Safety Technology Meeting (EDSTM) Program</a></li> </ul> </div> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_1 js-view-dom-id-0165a94066c77e718fe97d423b4a573209ac34f74062cd8589a127a32a43a68f"> </div> </div> </li> </ul> </nav> </div> </section> </aside> </article> </main> </div> </div> <div class="region region-subscribe"> <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> </section> </div> <footer class="lcds-footer container-fluid"> <div class="row lcds-footer__primary"> <h2 id="footer-heading" class="sr-only">Footer Links</h2> <nav class="text-center"> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li> <li><a href="/about-fda" >About FDA</a></li> <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/visitor-information" >Visitor Information</a> </li> <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li> <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li> <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure Policy</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li> <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li> <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li> </ul> </div> </nav> </div> <div class="row lcds-footer__secondary"> <div class="col-sm-12 col-md-6 col-lg-4 lcds-footer__social-links"> <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a> <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> <span class="fa fa-facebook fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Facebook</span> </span> </a> <a href="https://x.com/US_FDA" title="Follow FDA on X" class="no-disclaimer"> <svg class="icon-svg-inline fa-2x" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> <span class="sr-only">Follow FDA on X</span> </a> <a href="https://instagram.com/FDA" title="Follow FDA on Instagram" class="no-disclaimer"> <span class="fa fa-instagram fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Instagram</span> </span> </a> <br class='visible-xs-inline'/> <a href="https://www.linkedin.com/company/fda/" title="Follow FDA on LinkedIn" class="no-disclaimer"> <span class="fa fa-linkedin fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on LinkedIn</span> </span> </a> <a href="https://youtube.com/@US_FDA" title="View FDA videos on YouTube" class="no-disclaimer"> <span class="fa fa-youtube fa-2x" aria-hidden="true"> <span class="sr-only">View FDA videos on YouTube</span> </span> </a> <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds"> <span class="fa fa-rss fa-2x" aria-hidden="true"> <span class="sr-only">Subscribe to FDA RSS feeds</span> </span> </a> </div> <a href="/" title="FDA Homepage"> <div class="visible-lg-block col-lg-4 text-center lcds-footer__logo"> <span class="sr-only">FDA Homepage</span> </div> </a> <div class="col-sm-12 col-md-6 col-lg-4 text-center lcds-footer__contact-number"> <span class="fa fa-phone" aria-hidden="true"> </span> <span class="sr-only">Contact Number</span> 1-888-INFO-FDA (1-888-463-6332) </div> </div>  </footer> <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a> </div> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/422037","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"G-273DTKB5QW","trackOutbound":true,"trackMailto":true,"trackTel":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"3aef67b4ac7d861d8624bf1f7ab2bc9cfc56d3c25b7d709dc15466dfa996dfb0"}}</script> <script src="/files/js/js_KwaVrVDnb9vBN4UOzg4J4320oQW-EMMozpPhvFZziRU.js?scope=footer&delta=0&language=en&theme=preview&include=eJxlkFGOwyAMRC9EQ38q7W2QY1yCCjbCTqvs6Zu0ahrt_qBhLI3fGG8Us0kPmSOxjUXw5g_aXYUNHqRSyR_04JJIKhSAoSyWUf1fw-miRtWPoORap3umh09FRigntaVkTv9s7LmZulHE1Do036TJnbq7Rgj4YSWegJHqCqkeEKXHLBxM0gagk3RDieS2aPWvd6gS50LvHKmt5C3hPQuX88_BdA06pHX5pD72uUEZvs4wc5vHknWiuN5GjMVI_a72Rtjhd6H0rRihvaA-_x3ztDd4AlQhnP0"></script> <script type="text/javascript" src="/CYN0ID/cj/ae/JcXd/qZHXgkKvY6534/i5Ohp8JcDVbbk37k/QV4AAQ/ZygNN/QIJNV8B"></script></body> </html>

CINXE.COM

CDER Emerging Drug Safety Technology Program (EDSTP) | FDA